Hong Kong-headquartered Luqa Pharmaceuticals, a dermatology and other specialty company, has completed US$15 million new round of fund raising led by Morningside Ventures, according to a company announcement. Proceeds will be used to expand, develop and fund on-going operations and commercialization of Luqa's product range. Since the launch of its first product in 2013, Luqa […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.